PiB-conjugated, metal-based imaging probes: Multimodal approaches for the visualization of β-amyloid plaques

ACS Medicinal Chemistry Letters

Volumn 4, Issue 5, 2013, Pages 436-440

  Martins, André F ^a,b   Morfin, Jean François ^a   Kubíčková, Anna ^a,c   Kubíček, Vojtěch ^a   Buron, Frédéric ^d   Suzenet, Franck ^d   Salerno, Milena ^e   Lazar, Adina N ^f   Duyckaerts, Charles ^f   Arlicot, Nicolas ^g   Guilloteau, Denis ^g   Geraldes, Carlos F G C ^b   Tóth, Éva ^a  

^a CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITÉ D'ORLÉANS   (France)

^e UNIVERSITÉ PARIS 13   (France)

^f INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^g UNIVERSITÉ DE TOURS   (France)

Author keywords

111In3+; Alzheimer's disease; amyloid plaques; Gd3+; imaging agents; Pittsburgh compound B

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; CONTRAST MEDIUM; DO2A MONOAMIDE PITTSBURGH COMPOUND B GADOLINIUM; DO3A MONOAMIDE PITTSBURGH COMPOUND B IN 111; HUMAN SERUM ALBUMIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN TISSUE; COMPLEX FORMATION; DRUG DISTRIBUTION; DRUG PENETRATION; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84877710740     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400042w     Document Type: Article

References (33)

1. Evans, D. A.; Funkenstein, H. H.; Albert, M. S. Prevalence of Alzheimers-disease in a community population of older persons: higher than previously reported JAMA 1989, 262, 2551-2556
2. Fratiglioni, L.; Winblad, B.; von Strauss, E. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen project Physiol. Behav. 2007, 92, 98-104
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4 th ed; American Psychiatric Association: Washington, DC, 2000.
4. Braak, H.; Braak, E. Neuropathological staging of Alzheimer-related changes Acta Neuropathol. 1991, 82, 239-259
5. Hardy, J.; Selkoe, D. J. Medicine: The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 2002, 297, 353-356
6. Rauk, A. The chemistry of Alzheimer's disease Chem. Soc. Rev. 2009, 38, 2698-2715
7. Mathis, C. A.; Bacskai, B. J.; Kajdasz, S. T.; McLellan, M. E.; Frosch, M. P.; Hyman, B. T.; Holt, D. P.; Wang, Y.; Huang, G. F.; Debnath, M. L.; Klunk, W. E. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain Bioorg. Med. Chem. Lett. 2002, 12, 295-298
8. Vandenberghe, R.; Van Laere, K.; Ivanoiu, A.; Salmon, E.; Bastin, C.; Triau, E.; Hasselbalch, S.; Law, I.; Andersen, A.; Korner, A.; Minthon, L.; Garraux, G.; Nelissen, N.; Bormans, G.; Buckley, C.; Owenius, R.; Thurfjell, L.; Farrar, G.; Brooks, D. J. 18F-Flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial Ann. Neurol. 2010, 68, 319-29
9. Camus, V.; Payoux, P.; Barré, L.; Desgranges, B.; Voisin, T.; Tauber, C.; La Joie, R.; Tafani, M.; Hommet, C.; Chételat, G.; Mondon, K.; de La Sayette, V.; Cottier, J. P.; Beaufils, E.; Ribeiro, M. J.; Gissot, V.; Vierron, E.; Vercouillie, J.; Vellas, B.; Eustache, F.; Guilloteau, D. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment Eur. J. Nucl. Med. Mol. Imaging 2012, 39, 621-631
10. 18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study Lancet Neurol. 2011, 10, 424-435
11. Nesterov, E. E.; Skoch, J.; Hyman, B. T.; Klunk, W. E.; Bacskai, B. J.; Swager, T. M. In vivo optical Imaging of amyloid aggregates in brain: Design of fluorescent markers Angew. Chem., Int. Ed. 2005, 26, 5452-5456
12. Zhuang, Z. P.; Kung, M. P.; Hou, C.; Ploessl, K.; Kung, H. F. Biphenyls labeled with technetium 99m for imaging β-amyloid plaques in the brain Nucl. Med. Biol. 2005, 32, 171-184
13. 99mTc]- BAT-phenylbenzothiazole conjugate as a potential in vivo tracer for visualization of amyloid β Bioorg. Med. Chem. Lett. 2007, 17, 6086-6090
14. Ono, M.; Ikeoka, R.; Watanabe, H.; Kimura, H.; Fuchigami, T.; Haratake, M.; Saji, H.; Nakayama, M. Synthesis and evaluation of novel chalcone derivatives with 99mTc/Re complexes as potential probes for detection of β-amyloid plaques ACS Chem. Neurosci. 2010, 1, 598
15. 99mTc/Re complexes based on flavone and aurone as SPECT probes for imaging cerebral β-amyloid plaques Bioorg. Med. Chem. Lett. 2010, 20, 5743-5748
16. Cheng, Y.; Ono, M.; Kimura, H.; Ueda, M.; Saji, H. Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains J. Med. Chem. 2012, 55, 2279-2286
17. Toth, E.; Merbach, A., Eds. The Chemistry of Contrast Agents in Medical MRI; John Wiley & Sons: Chichester, U.K., 2001.
18. Jack, C. R.; Garwood, M.; Wengenack, T. M.; Borowski, B.; Curran, G. L.; Lin, J.; Adriany, G.; Grohn, I. H. J.; Grimm, R.; Poduslo, J. F. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent Magn. Reson. Med. 2004, 52, 1263-1271
19. Poduslo, J. F.; Wengenack, T. M.; Curran, G. L.; Wisniewski, T.; Sigurdsson, E. M.; Macura, S. I.; Borowski, B. J.; Jack, C. R., Jr. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging Neurobiol. Dis. 2002, 11, 315-329
20. Yang, J.; Wadghiri, Y. Z.; Hoang, D. M.; Tsui, W.; Sun, Y. J.; Chung, E.; Li, Y. S.; Wang, A.; de Leon, M.; Wisniewski, T. Detection of amyloid plaques targeted by USPIO-A beta 1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging Neuroimage 2011, 55, 1600-1609
21. Mathis, C. A.; Wang, Y.; Holt, D. P.; Huang, G.-F.; Debnath, M. L.; Klunk, W. E. Synthesis and evaluation of C-11-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J. Med. Chem. 2003, 46, 2740-2754
22. Yona, R. L.; Mazères, S.; Faller, P.; Gras, E. Thioflavin derivatives of amyloid-β fibrils: insights into structural features important for high-affinity binding ChemMedChem 2008, 3, 63-66
23. Mensch, J.; Oyarzabal, J.; Mackie, C.; Augustijns, P. In vivo, in vitro and in silico methods for small molecule transfer across the BBB J. Pharm. Sci. 2009, 98, 4429-4468
24. Aime, S.; Fasano, M.; Terreno, E.; Botta, M. Protein-Bound Metal Chelates. In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; Merbach, A.E.; Toth, E., Eds.; Wiley: New York, 2001; Chapter 5, pp 194-241.
25. Nicolle, G. M.; Tóth, é.; Eisenwiener, K.-P.; Mäcke, H. R.; Merbach, A. E. From monomers to micelles: investigation of the parameters influencing proton relaxivity J. Biol. Inorg. Chem. 2002, 7, 757-769
26. Lin, K.-S.; Debnath, M. L.; Mathis, C. A.; Klunk, W. E. Synthesis and beta-amyloid binding properties of rhenium 2-phenylbenzothiazoles Bioorg. Med. Chem. Lett. 2009, 19, 2258-2262
27. Prata, M. I. M.; Santos, A. C.; Bligh, S. W. A.; Chowdhury, A. H. M. S.; Geraldes, C. F. G. C.; de Lima, J. J. P. Characterization of In-111(3+) complexes of DTPA amide derivatives: Biodistribution and clearance studied by gamma imaging Nucl. Med. Biol. 2000, 27, 605-610
28. Levin, V. Relationship of octanol-water partition-coefficient and molecular-weight to rat brain capillary-permeability J. Med. Chem. 1980, 23, 682-684
29. Bornebroek, M.; Verzijlbergen, J.; Haan, J.; Van Scheyen, E.; Verhoeff, N.; Pauwels, E.; Roos, R. Potential for imaging cerebral amyloid deposits using I-123-labelled serum amyloid P component and SPET Nucl. Med. Commun. 1996, 17, 929-933
30. Saito, Y.; Buciak, J.; Yang, J.; Pardridge, W. M. Vector-mediated delivery of I-125 labeled beta-amyloid peptide A-beta(1-40) through the blood-brain-barrier and binding to Alzheimer-disease amyloid of the A-beta(1-40)/vector complex Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 10227
31. Emond, P.; Guilloteau, D.; Chalon, S. PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter CNS Neurosci. Ther. 2008, 14, 47-64
32. Arlicot, N.; Katsifis, A.; Garreau, L.; Mattner, F.; Vergote, J.; Duval, S.; Kousignian, I.; Bodard, S.; Guilloteau, D.; Chalon, S. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 2203-2211
33. Petiet, A.; Dhenain, M. Improvement of microscopic MR imaging if amyloid plaques with targeting and non-targeting contrast agents Curr. Med. Imaging Rev. 2011, 7, 1-8